Andrews Timothy K. 4
4 · Sienna Biopharmaceuticals, Inc. · Filed Aug 1, 2017
Insider Transaction Report
Form 4
Andrews Timothy K.
General Counsel & Secretary
Transactions
- Purchase
Common Stock
2017-08-01$15.00/sh+15,000$225,000→ 15,000 total(indirect: See Footnote)
Holdings
- 51,737
Common Stock
Footnotes (2)
- [F1]The Reporting Person purchased the shares of the Issuer's common stock in connection with the Issuer's initial public offering at the offering price of $15.00 per share.
- [F2]The shares are directly held by Steelhead Bioventures LLC, a limited liability company in which the Reporting Person holds a controlling interest.